Publikationen von Matthias Lienhard
Alle Typen
Zeitschriftenartikel (37)
1.
Zeitschriftenartikel
: Long-read transcriptome sequencing of CLL and MDS patients uncovers molecular effects of SF3B1 mutations. Genome Research 34 (11), S. 1832 - 1848 (2024)
2.
Zeitschriftenartikel
: Systematic assessment of long-read RNA-seq methods for transcript identification and quantification. Nature Methods 21 (7), S. 1349 - 1363 (2024)
3.
Zeitschriftenartikel
: Depletion of TBC1D4 improves the metabolic exercise response by overcoming genetically induced peripheral insulin resistance. Diabetes 73 (7), S. 1058 - 1071 (2024)
4.
Zeitschriftenartikel
6 (2), Article lqae043 (2024)
Cancer drug sensitivity estimation using modular deep Graph Neural Networks. NAR: Genomics and Bioinformatics 5.
Zeitschriftenartikel
: Neurofibromin 1 controls metabolic balance and Notch-dependent quiescence of murine juvenile myogenic progenitors. Nature Communications 15 (1), 1393 (2024)
6.
Zeitschriftenartikel
39 (6), btad364 (2023)
IsoTools: a flexible workflow for long-read transcriptome sequencing analysis. Bioinformatics 7.
Zeitschriftenartikel
: Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusion. Cardiovascular Diabetology 22, 17 (2023)
8.
Zeitschriftenartikel
: Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies. Blood 140 (20), S. 2113 - 2126 (2022)
9.
Zeitschriftenartikel
: Multi-omics HeCaToS dataset of repeated dose toxicity for cardiotoxic & hepatotoxic compounds. Scientific Data 9, 699 (2022)
10.
Zeitschriftenartikel
14 (16), 3950 (2022)
Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction. Cancers / Molecular Diversity Preservation International (MDPI) 11.
Zeitschriftenartikel
27 (6), 173 (2022)
Epirubicin Alters DNA Methylation Profiles Related to Cardiotoxicity. Frontiers in Bioscience-Landmark 12.
Zeitschriftenartikel
4 (1), lqab128 (2022)
Matching anticancer compounds and tumor cell lines by neural networks with ranking loss. NAR: genomics and bioinformatics 13.
Zeitschriftenartikel
: Altered DNA Methylation Profiles in SF3B1 Mutated CLL Patients. International Journal of Molecular Sciences 22 (17), 9337 (2021)
14.
Zeitschriftenartikel
19, 19:274 (2021)
Large-scale literature mining to assess the relation between anti-cancer drugs and cancer types. Journal of Translational Medicine 15.
Zeitschriftenartikel
: Crowdsourced mapping of unexplored target space of kinase inhibitors. Nature Communications 12, 3307 (2021)
16.
Zeitschriftenartikel
: PWD/Ph-encoded genetic variants modulate the cellular Wnt/β-Catenin response to suppress ApcMin-triggered intestinal tumor formation. Cancer research: an official organ of the American Association for Cancer Research 81 (1), S. 38 - 49 (2021)
17.
Zeitschriftenartikel
: Network integration and modelling of dynamic drug responses at multi-omics levels. Communications Biology 3 (1), 573 (2020)
18.
Zeitschriftenartikel
: DMSO induces drastic changes in human cellular processes and epigenetic landscape in vitro. Scientific Reports 9 (9), 4641 (2019)
19.
Zeitschriftenartikel
: Combined Targeted Re-Sequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for PARP1 Inhibitor Sensitivity Testing. The Journal of Molecular Diagnostics 21 (2), S. 198 - 213 (2019)
20.
Zeitschriftenartikel
: Combined Targeted Resequencing of Cytosine DNA Methylation and Mutations of DNA Repair Genes with Potential Use for Poly(ADP-Ribose) Polymerase 1 Inhibitor Sensitivity Testing. The Journal of Molecular Diagnostics 21 (2), S. 198 - 213 (2019)